[go: up one dir, main page]

WO2010038154A3 - Polymorphic forms of rosiglitazone hydrogensulfate and processes for their preparation - Google Patents

Polymorphic forms of rosiglitazone hydrogensulfate and processes for their preparation Download PDF

Info

Publication number
WO2010038154A3
WO2010038154A3 PCT/IB2009/007156 IB2009007156W WO2010038154A3 WO 2010038154 A3 WO2010038154 A3 WO 2010038154A3 IB 2009007156 W IB2009007156 W IB 2009007156W WO 2010038154 A3 WO2010038154 A3 WO 2010038154A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogensulfate
rosiglitazone
processes
preparation
polymorphic forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/007156
Other languages
French (fr)
Other versions
WO2010038154A2 (en
Inventor
Sonny Sebastian
Balla Venkata Sasidhar
Challa Krishna
Nitin Sharadchandra Pradhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Group PTC ehf
Original Assignee
Actavis Group PTC ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group PTC ehf filed Critical Actavis Group PTC ehf
Publication of WO2010038154A2 publication Critical patent/WO2010038154A2/en
Publication of WO2010038154A3 publication Critical patent/WO2010038154A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided also herein are novel polymorphic forms of rosiglitazone hydrogensulfate, processes for the preparation, pharmaceutical compositions, and method of treating thereof.
PCT/IB2009/007156 2008-10-03 2009-09-29 Polymorphic forms of rosiglitazone hydrogensulfate and processes for their preparation Ceased WO2010038154A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2442/CHE/2008 2008-10-03
IN2442CH2008 2008-10-03

Publications (2)

Publication Number Publication Date
WO2010038154A2 WO2010038154A2 (en) 2010-04-08
WO2010038154A3 true WO2010038154A3 (en) 2010-07-29

Family

ID=41426843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/007156 Ceased WO2010038154A2 (en) 2008-10-03 2009-09-29 Polymorphic forms of rosiglitazone hydrogensulfate and processes for their preparation

Country Status (1)

Country Link
WO (1) WO2010038154A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050113A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050113A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione

Also Published As

Publication number Publication date
WO2010038154A2 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
WO2010062715A3 (en) Polymorphs of dasatinib and process for preparation thereof
WO2010122578A3 (en) Process for preparation of sitagliptin and its intermediates
WO2009108860A3 (en) Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
AP2012006191A0 (en) Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same.
BRPI1008021A2 (en) Method for the manufacture of 2,6-dioxabicyclo- (3.3.0) -octane-4,8-dione
ZA201007526B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene
ZA201008097B (en) Process for the preparation of 2,3,3,3-trifluoropropene
WO2009067674A3 (en) Polymorphs of sunitinib base and processes for preparation thereof
WO2009158719A3 (en) Methods and compositions for treating disorders
WO2008027600A3 (en) Imatinib compositions
WO2009130604A3 (en) Solid state forms of deferasirox salts and process for the preparation thereof
WO2007132354A3 (en) Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2010011834A3 (en) Process for the preparation of sunitinib malate via sunitinib acetate and their polymorphs
WO2009094457A3 (en) Substituted benzhydrylethers
WO2010016931A3 (en) Polymorphs of fluticasone furoate and process for preparation thereof
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2011067236A3 (en) Raltegravir polymorphs
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
WO2008104957A3 (en) Novel polymorphic forms of milnacipran hydrochloride
WO2008125239A3 (en) Dry extracts of pelargonium sidoides and pelargonium reniforme
WO2008019053A3 (en) Process for preparing clopidogrel bisulphate
WO2008041176A3 (en) Process for the preparation of form i and form ii of ritonavir
WO2008111018A3 (en) Process for the preparation of crystals of prulifloxacin
SI2473492T1 (en) Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo(2,2.1)hept-5-enes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09744451

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09744451

Country of ref document: EP

Kind code of ref document: A2